Search

Home > GRACEcast Lung Cancer Video > The Role of EGFR Inhibitor Therapy as Post-Operative Treatment for Early Stage NSCLC: A Controversial Question (video)
Podcast: GRACEcast Lung Cancer Video
Episode:

The Role of EGFR Inhibitor Therapy as Post-Operative Treatment for Early Stage NSCLC: A Controversial Question (video)
Category: Science & Medicine
Duration: 00:33:46
Publish Date: 2010-03-17 12:01:00
Description:

Dr. Jared Weiss, medical oncologist from the Univ. of Pennsylvania, covers limited data and current clinical trials addressing potential role of EGFR inhibitors, and particularly Tarceva (erlotinib), as post-surgical treatment for advanced NSCLC.
Total Play: 0